BVZD-ABDH Study Day: Secure reuse of routine care data - benefits and challenges


  • 16 March 2021 (12h00-14h00)
  • Virtual event

Advances in medical research and the development of novel insights increasingly depend on the availability and secure reuse and analysis of routine care data. Each encounter of a patient with the healthcare system leaves a trail of data. In an ideal world, every such encounter also represents an opportunity to learn. However, for now, there are multiple challenges with secure reuse of routine care data. First and foremost is of course the challenge to preserve patient privacy. Other challenges may be around topics like interoperability, governance structures, analytical methods etc …

In the upcoming seminar, we will explore various of those angles and present you with a number of cases in which secure and successful reuse of routine care data has led to proven results which benefit the patient, the healthcare system and/or the life-sciences research ecosystem.


  • 12:00: Introductions
  • Prof. Pascal Verdonck, Vice-president BVZD-ABDH & Prof. Walter Van Dyck, Associate Professor Technology & Innovation Management and Partner at Vlerick Business School

Overall needs, challenges and possible benefits

  • 12:10: view for Hospital
  • Dr. Peter Thijs, CIO ZOL Genk & Mrs. Noella Pierlet, coordinator clinical data ZOL Genk

  • 12:20: view form pharma
  • Mr. Bart Vannieuwenhuyse, director health information sciences Janssen

Use cases

  • 12:30
  • OLV Hospital Aalst: Dr. Peter Schatteman, urologist OLV Aalst

  • 12:40
  • CHU Liège: Prof. Philippe Kolh, CIO CHU Liège

  • 12:50
  • Pharma use case: Mr. Jan Vertriest, RWD Manager MSD

Doing the right way

  • 13:00
  • Data governance framework: Mr. Diego Fornaciari, Resolut Law

  • 13:10
  • Example from AZ Delta: Mr. Joost de Rore, director IT and data AZ Delta

  • 13:20
  • Privacy preserving analytics: Prof. Yves Moreau, STADIUS KU Leuven

  • 13:30
  • Panel discussion: Moderated by Prof. Walter Van Dyck

Please register via following link:

Other news